Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 5/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.52 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.52 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.52 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.48 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.48 |
| ▸ | XDH | P47989 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 3/20 | 0.44 |
| ▸ | RAB9A | P51151 | 3/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2294016 | 1.00 | CYP1A2 (0.57) | CYP1A2ALDH1A1MAPTKDM4ELMNA | |
| SCHEMBL29349761 | 0.86 | CYP1A2 (0.59) | CYP1A2ALDH1A1MAPTKDM4ELMNA | |
| SCHEMBL1825727 | 0.81 | CYP1A2 (0.64) | CYP1A2ALDH1A1MAPTKDM4ELMNA | |
| SCHEMBL1825729 | 0.81 | CYP1A2 (0.64) | CYP1A2ALDH1A1MAPTKDM4ELMNA | |
| SCHEMBL1310216 | 0.81 | ALDH1A1 (0.75) | ALDH1A1MAPTKDM4ELMNAMAPK1 | |
| SCHEMBL1310214 | 0.81 | ALDH1A1 (0.75) | ALDH1A1MAPTKDM4ELMNAMAPK1 | |
| SCHEMBL13991702 | 0.80 | ALDH1A1 (0.47) | CYP1A2ALDH1A1MAPTKDM4ELMNA | |
| SCHEMBL14494738 | 0.80 | ALDH1A1 (0.47) | CYP1A2ALDH1A1MAPTKDM4ELMNA | |
| SCHEMBL5441911 | 0.80 | CYP1A2 (0.59) | CYP1A2ALDH1A1MAPTKDM4ELMNA | |
| SCHEMBL5441914 | 0.80 | CYP1A2 (0.59) | CYP1A2ALDH1A1MAPTKDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100256421-A1 | Propanal Production Methods | O'LAUGHLIN INDUSTRIES, CO. LTD. (CN) | 2010-10-07 | — | — | US | claimed |
| EP-2233556-A1 | Isomeric mixture of meta and para tertio-butylphenyl propanal and production thereof | O'Laughlin Industries, Co. Ltd. (HK) | 2010-09-29 | — | — | EP | claimed |
| EP-0966456-B1 | TAXOID REVERSAL AGENTS FOR DRUG-RESISTANCE IN CANCER CHEMOTHERAPY AND PHARMACEUTICAL COMPOSITIONS THEREOF | UNIV NEW YORK STATE RES FOUND (US) | 2003-04-02 | — | — | EP | claimed |
| EP-0966456-A4 | TAXOID REVERSAL AGENTS FOR DRUG-RESISTANCE IN CANCER CHEMOTHERAPY AND PHARMACEUTICAL COMPOSITIONS THEREOF | RES FOUNDATION OF (US) | 2000-07-26 | — | — | EP | claimed |
| EP-0966456-A1 | TAXOID REVERSAL AGENTS FOR DRUG-RESISTANCE IN CANCER CHEMOTHERAPY AND PHARMACEUTICAL COMPOSITIONS THEREOF | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 1999-12-29 | — | — | EP | claimed |
| US-5811452-A | ADMINISTERING WITH PACLITAXEL OR DOXORUBICIN | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 1998-09-22 | — | — | US | claimed |
| WO-1998030553-A1 | TAXOID REVERSAL AGENTS FOR DRUG-RESISTANCE IN CANCER CHEMOTHERAPY AND PHARMACEUTICAL COMPOSITIONS THEREOF | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 1998-07-16 | — | — | WO | claimed |
| EP-0652861-B1 | NOVEL AROMATIC COMPOUNDS AND THEIR USE IN PERFUME PRODUCTS | FIRMENICH & CIE (CH) | 1997-09-03 | — | — | EP | claimed |
| EP-0652861-A1 | NOVEL AROMATIC COMPOUNDS AND THEIR USE IN PERFUME PRODUCTS. | FIRMENICH & CIE (CH) | 1995-05-17 | — | — | EP | claimed |
| WO-1994027946-A1 | NOVEL AROMATIC COMPOUNDS AND THEIR USE IN PERFUME PRODUCTS | FIRMENICH S.A. (CH) | 1994-12-08 | — | — | WO | claimed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| CN-112979632-B | Synthesis method of 4-hydroxy-1, 3-thiazine-2-thioketone compound | 台州学院 | 2022-08-30 | — | — | CN | disclosed |
| US-11225655-B2 | Bi-functional complexes and methods for making and using such complexes | NUEVOLUTION A/S (DK) | 2022-01-18 | — | — | US | disclosed |
| CN-112979632-A | Synthesis method of 4-hydroxy-1, 3-thiazine-2-thioketone compound | 台州学院 | 2021-06-18 | — | — | CN | disclosed |
| CN-107641086-B | Synthetic method of nitroolefin compound | 浙江工业大学 | 2020-05-22 | — | — | CN | disclosed |
| US-5811452-A | ADMINISTERING WITH PACLITAXEL OR DOXORUBICIN | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 1998-09-22 | — | — | US | disclosed |
| WO-1998030553-A1 | TAXOID REVERSAL AGENTS FOR DRUG-RESISTANCE IN CANCER CHEMOTHERAPY AND PHARMACEUTICAL COMPOSITIONS THEREOF | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 1998-07-16 | — | — | WO | disclosed |
| US-4996365-A | Preparation of alkyl-substituted cinnamaldehydes | BASF AKTIENGESELLSCHAFT (DE) | 1991-02-26 | — | — | US | disclosed |
| US-4950467-A | SUNSCREEN AGENT CONTAINING 5-PHENYL-PENTADIENOATE ESTER | ICI AMERICAS INC. (US) | 1990-08-21 | — | — | US | disclosed |
| US-4087549-A | Sulphonic acid containing indenyl derivatives | MERCK & CO., INC. (US) | 1978-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100256421-A1 | Propanal Production Methods | ALDH2, ALDH1A3, TERT | CYP1A2 475/4885ALDH1A1 4/4885MAPT 1064/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.